ametantrone has been researched along with Acute Myelogenous Leukemia in 1 studies
ametantrone: RN given refers to parent cpd; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone was 10-20 fold more potent against AML cells than ametantrone." | 1.27 | Comparison of mitoxantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cells. ( Fountzilas, G; Holland, JF; Mindich, B; Ohnuma, T; Rammos, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fountzilas, G | 1 |
| Ohnuma, T | 1 |
| Rammos, K | 1 |
| Mindich, B | 1 |
| Holland, JF | 1 |
1 other study available for ametantrone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Comparison of mitoxantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cells.
Topics: Anthraquinones; Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cell Survival; Colony-Formi | 1986 |